Arcutis Biotherapeutics Inc (ARQT)vsInsmed Inc (INSM)
ARQT
Arcutis Biotherapeutics Inc
$22.74
+4.17%
HEALTHCARE · Cap: $2.71B
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 61% more annual revenue ($606.42M vs $376.07M). INSM leads profitability with a -2.1% profit margin vs -4.3%. INSM earns a higher WallStSmart Score of 39/100 (F).
ARQT
Hold36
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 81.5% year-over-year
No standout strengths identified
Areas to Watch
Trading at 14.8x book value
0.0% earnings growth
ROE of -9.3% — below average capital efficiency
Distress zone — elevated risk
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ARQT
The strongest argument for ARQT centers on Revenue Growth. Revenue growth of 81.5% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : ARQT
The primary concerns for ARQT are Price/Book, EPS Growth, Return on Equity.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
ARQT profiles as a hypergrowth stock while INSM is a turnaround play — different risk/reward profiles.
ARQT carries more volatility with a beta of 1.74 — expect wider price swings.
ARQT is growing revenue faster at 81.5% — sustainability is the question.
ARQT generates stronger free cash flow (26M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arcutis Biotherapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?